Search Within

Katherine Rodriguez

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (6)
  4. Department of Pathology and Laboratory Medicine (4)
  5. GSK Faculty (3)
  6. Hematologic Malignancies, Division of (2)

More Groups

People
  1. Camelia Sima (4)
  2. Gregory Riely (4)
  3. Helena Yu (4)
  4. Jarushka Naidoo (4)
  5. Mark Kris (4)
  6. Natalie Busby (4)

More People

Years
  1. 2024 (1)
  2. 2017 (1)
  3. 2015 (3)
  4. 2014 (2)
Publications
  1. Cancer (2)
  2. Journal of Clinical Oncology (2)
  3. Clinical Cancer Research (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. Journal of Thoracic Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (2)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy
    Journal Article

    Naidoo, J.; Wang, X.; Woo, K. M.; Iyriboz, T.; Halpenny, D.; Cunningham, J.; Chaft, J. E.; Segal, N. H.; Callahan, M. K.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
    Journal Article

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Nafa, K.; Ladanyi, M.; Riely, G. J.; Kris, M. G.; Arcila, M. E.; Yu, H. A.
    Cancer (2015)

    Fulltext@MSK | Save
  • Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas
    Journal Article

    Yu, H. A.; Sima, C. S.; Hellmann, M. D.; Naidoo, J.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Cancer (2015)

    Fulltext@MSK | Save
  • Stage at diagnosis as a prognostic marker for patients with KRAS-mutant metastatic lung adenocarcinomas
    Meeting Abstract

    Yu, H. A.; Hellmann, M. D.; Sima, C. S.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • EGFR exon 20 alterations in lung adenocarcinomas and their impact on overall survival and response to EGFR TKI
    Meeting Abstract

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Arcila, M. E.; Yu, H. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save